Skip to main content

Odonate Therapeutics, Inc.

ODTDelisted Jan 25, 2022
Industry
Pharmaceutical Preparations
SEC CIK
0001717452

Odonate Therapeutics, Inc. was delisted on Jan 25, 2022; its insiders filed their last Form 4 on Dec 10, 2021; 50 institutions reported holding it in 13F filings for Q4 2021, worth $32.7M in total; no superinvestor held it.

Q3 2021 vs. Q2 2021

How the institutions holding Odonate Therapeutics, Inc. changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of ODT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Q3 2021Change
Holders6958−11
Shares32.9M32.6M−321.4K (−1.0%)
Value$115.0M$94.9M−$20.0M (−17.4%)

New holders (6)

Institutions that held Odonate Therapeutics, Inc. at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to ODT in Q3 2021
InstitutionSharesValue% of portfolio
Jacobs Levy Equity Management, Inc102,409$298.0K0.00%
MYDA Advisors LLC89,974$262.0K0.10%
Renaissance Technologies LLC33,100$96.0K0.00%
Rafferty Asset Management, LLC30,101$88.0K0.00%
Wolverine Trading, LLC11,556$35.0K0.00%
Quantbot Technologies LP2,300$6.00K0.00%

Sold out (17)

Institutions that held Odonate Therapeutics, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.